[Albuminuria : prognostic marker or therapeutic goal?]. / Albuminurie : Prognostischer Marker oder therapeutisches Ziel?
Internist (Berl)
; 53(1): 38-44, 2012 Jan.
Article
en De
| MEDLINE
| ID: mdl-22231694
ABSTRACT
Microalbuminuria has most often been linked with renal disease in diabetic patients. However, accumulating data demonstrate that the development of albuminuria is closely associated with cardiovascular and renal disease in both diabetic and non-diabetic patients. The role of albuminuria in the pathogenesis of these clinical conditions remains controversial. While reductions in albuminuria have been associated with improved outcomes, the evidence for lower levels of albuminuria (microalbuminuria and normoalbuminuria) is inconclusive. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have demonstrated some success in treating or delaying the onset of microalbuminuria. However, it remains to be established whether these effects result in meaningful reductions in clinical renal or cardiovascular events.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Inhibidores de la Enzima Convertidora de Angiotensina
/
Enfermedades Cardiovasculares
/
Albuminuria
/
Antagonistas de Receptores de Angiotensina
Tipo de estudio:
Prognostic_studies
Límite:
Humans
Idioma:
De
Revista:
Internist (Berl)
Año:
2012
Tipo del documento:
Article